{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:19:16Z","timestamp":1770999556697,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.cytogfr.2010.03.003","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T09:01:35Z","timestamp":1272013295000},"page":"263-273","source":"Crossref","is-referenced-by-count":57,"title":["High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms"],"prefix":"10.1016","volume":"21","author":[{"given":"Masato","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Nakagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce C.","family":"Trapnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2010.03.003_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(81)91460-4","article-title":"Patient with circulating antibodies to alpha-interferon","volume":"2","author":"Mogensen","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/289496a0","article-title":"Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon","volume":"289","author":"Vallbracht","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/anr.1780321206","article-title":"Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis","volume":"32","author":"Suzuki","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-3083.1989.tb01149.x","article-title":"IgG autoantibodies against interleukin 1 alpha in sera of normal individuals","volume":"29","author":"Svenson","year":"1989","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0167-5699(98)01252-3","article-title":"High-avidity autoantibodies to cytokines","volume":"19","author":"Bendtzen","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib6","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1172\/JCI116862","article-title":"Binding of cytokines to pharmaceutically prepared human immunoglobulin","volume":"92","author":"Svenson","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib7","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V91.6.2054","article-title":"Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations","volume":"91","author":"Svenson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib8","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI117881","article-title":"High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG","volume":"95","author":"Ross","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib9","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1182\/blood.V90.6.2376","article-title":"Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy","volume":"90","author":"Ross","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1164\/ajrccm.162.2.9910032","article-title":"Serological diagnosis of idiopathic pulmonary alveolar proteinosis","volume":"162","author":"Kitamura","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib12","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2008-05-155689","article-title":"Granulocyte\/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects","volume":"113","author":"Uchida","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib13","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.febslet.2007.04.029","article-title":"Anti-cytokine autoantibodies are ubiquitous in healthy individuals","volume":"581","author":"Watanabe","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa062505","article-title":"GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis","volume":"356","author":"Uchida","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib15","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1097\/00003246-200210000-00024","article-title":"Anti-interleukin-8 autoantibodies in patients at risk for acute respiratory distress syndrome","volume":"30","author":"Kurdowska","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1164\/ajrccm.163.2.2005109","article-title":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity","volume":"163","author":"Kurdowska","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","article-title":"High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis","volume":"103","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib18","first-page":"62","article-title":"Detection of anti-interferon-gamma autoantibodies in subjects infected by Mycobacterium tuberculosis","volume":"2","author":"Madariaga","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2362.1998.00279.x","article-title":"Cytokine autoantibodies in multiple sclerosis, aseptic meningitis and stroke","volume":"28","author":"Elkarim","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1034\/j.1600-0765.2003.02001.x","article-title":"Interleukin-8 and anti-interleukin-8 autoantibodies in gingival crevicular fluid from patients with periodontitis","volume":"38","author":"Kurdowska","year":"2003","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0165-5728(97)00008-8","article-title":"Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF","volume":"75","author":"Dicou","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib22","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.157.6.2699","article-title":"Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome","volume":"157","author":"Kurdowska","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib23","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/art.10497","article-title":"Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus","volume":"46","author":"Hellmich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ajh.21241","article-title":"Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies","volume":"83","author":"Hara","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib25","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"Patel","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.180.1.647","article-title":"Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6","volume":"180","author":"Puel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib27","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.61.7.598","article-title":"Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome","volume":"61","author":"Graudal","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-3083.1997.d01-139.x","article-title":"High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study","volume":"46","author":"Jouvenne","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaut.2004.02.003","article-title":"Reduced anti-TNFalpha autoantibody levels coincide with flare in systemic lupus erythematosus","volume":"22","author":"Sj\u00f6wall","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib31","doi-asserted-by":"crossref","first-page":"L1105","DOI":"10.1152\/ajplung.00277.2003","article-title":"Proinflammatory activity of anti-IL-8 autoantibody:IL-8 complexes in alveolar edema fluid from patients with acute lung injury","volume":"286","author":"Krupa","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4049\/jimmunol.152.2.935","article-title":"IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis","volume":"152","author":"Suzuki","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib33","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/eji.200425268","article-title":"High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors","volume":"34","author":"Galle","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib34","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1056\/NEJMra023226","article-title":"Pulmonary alveolar proteinosis","volume":"349","author":"Trapnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0609.2004.00348.x","article-title":"Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia","volume":"73","author":"Casadevall","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib37","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.1780401216","article-title":"Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia","volume":"40","author":"Tzioufas","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM199603073341004","article-title":"Autoantibodies against erythropoietin in a patient with pure red-cell aplasia","volume":"334","author":"Casadevall","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib39","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"D\u00f6ffinger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"H\u00f6flich","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib41","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2169\/internalmedicine.46.6452","article-title":"Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma","volume":"46","author":"Tanaka","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib42","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib43","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","article-title":"Autoimmune polyendocrine syndromes","volume":"350","author":"Eisenbarth","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.immunol.25.022106.141532","article-title":"Aire","volume":"27","author":"Mathis","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-3083.1996.d01-344.x","article-title":"Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis","volume":"44","author":"Homann","year":"1996","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/CS20070272","article-title":"Anti-interleukin-8 autoantibody:interleukin-8 immune complexes in acute lung injury\/acute respiratory distress syndrome","volume":"114","author":"Fudala","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib47","doi-asserted-by":"crossref","first-page":"L364","DOI":"10.1152\/ajplung.00179.2006","article-title":"Anti-IL-8 autoantibody:IL-8 immune complexes suppress spontaneous apoptosis of neutrophils","volume":"293","author":"Fudala","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib48","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/art.1780350814","article-title":"Anti-interleukin-6 autoantibodies in rheumatic diseases. Increased frequency in the sera of patients with systemic sclerosis","volume":"35","author":"Takemura","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00269199","article-title":"Presence of interferon and anti-interferon in patients with systemic lupus erythematosus","volume":"8","author":"von Wussow","year":"1988","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2249.1991.tb05686.x","article-title":"Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis","volume":"85","author":"Ikeda","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0753-3322(00)00018-4","article-title":"Autoantibodies to TNFalpha in HIV-1 infection: prospects for anti-cytokine vaccine therapy","volume":"55","author":"Capini","year":"2001","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1440-1746.1989.tb01738.x","article-title":"Detection of anti-interferon-alpha 2a antibodies in chronic liver disease","volume":"4","author":"Ikeda","year":"1989","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib54","first-page":"611","article-title":"Individuals infected with HIV possess antibodies against IL-2","volume":"65","author":"Bost","year":"1988","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib55","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00595-005-3047-y","article-title":"Thymoma and thymic carcinoma: an update of the WHO Classification 2004","volume":"35","author":"Strobel","year":"2005","journal-title":"Surg Today"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/intimm\/dxg088","article-title":"Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor","volume":"15","author":"Shiono","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib57","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0952-7915(02)00349-7","article-title":"Interferon-producing cells: on the front line in immune responses against pathogens","volume":"14","author":"Colonna","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI11734","article-title":"Human thymus contains IFN-alpha-producing CD11c(\u2212), myeloid CD11c(+), and mature interdigitating dendritic cells","volume":"107","author":"Bendriss-Vermare","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2362.1994.tb00991.x","article-title":"Sex- and age-dependency of IgG auto-antibodies against IL-1 alpha in healthy humans","volume":"24","author":"Hansen","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib61","first-page":"89","article-title":"Age-related increase of autoantibodies to interleukin 1 alpha in healthy Japanese blood donors","volume":"44","author":"Ohmoto","year":"1997","journal-title":"J Med Invest"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib62","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-3083.1990.tb03212.x","article-title":"Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera","volume":"32","author":"Svenson","year":"1990","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/1043-4666(93)90026-2","article-title":"High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro","volume":"5","author":"Hansen","year":"1993","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<219::AID-JCP25>3.0.CO;2-9","article-title":"Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum","volume":"173","author":"Laricchia Robbio","year":"1997","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.thj.6200082","article-title":"Naturally-occurring anti-G-CSF antibodies produced by human cord blood B-cell lines infected with Epstein-Barr virus","volume":"2","author":"Revoltella","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/cimm.2000.1704","article-title":"Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein\u2013Barr virus in vitro","volume":"204","author":"Revoltella","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib67","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-3083.1993.tb02590.x","article-title":"The detection and biological activity of human antibodies to IL-2 in normal donors","volume":"38","author":"Tiberio","year":"1993","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib68","first-page":"7","article-title":"Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase","volume":"79","author":"Balleari","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib69","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1172\/JCI115883","article-title":"Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum","volume":"90","author":"Sylvester","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0161-5890(96)00017-X","article-title":"Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor","volume":"33","author":"Garrone","year":"1996","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib71","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1073\/pnas.87.24.9655","article-title":"Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor","volume":"87","author":"Hayashida","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib72","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1073\/pnas.86.22.8946","article-title":"Cloning the interleukin 1 receptor from human T cells","volume":"86","author":"Sims","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib73","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0092-8674(90)90411-7","article-title":"Molecular cloning and expression of an IL-6 signal transducer, gp130","volume":"63","author":"Hibi","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib74","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1073\/pnas.89.15.7041","article-title":"Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit","volume":"89","author":"Tavernier","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib75","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.4049\/jimmunol.152.4.1821","article-title":"Expression cloning and characterization of a human IL-10 receptor","volume":"152","author":"Liu","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib76","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/MCB.15.8.4208","article-title":"Ligand-induced association of the type I interferon receptor components","volume":"15","author":"Cohen","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-2478(93)90098-M","article-title":"Purification of interleukin-2 antibodies from healthy individuals","volume":"36","author":"Monti","year":"1993","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2249.1990.tb05403.x","article-title":"Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors","volume":"82","author":"Ross","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0162-3109(94)90058-2","article-title":"An anti-IL-2 antibody increases serum half-life and improves anti-tumor efficacy of human recombinant interleukin-2","volume":"28","author":"Courtney","year":"1994","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib80","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4049\/jimmunol.151.3.1235","article-title":"Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes","volume":"151","author":"Finkelman","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib81","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01878084","article-title":"Enhancement of anti-tumor activity of recombinant interleukin-2 (rIL-2) by immunocomplexing with a monoclonal antibody against rIL-2","volume":"6","author":"Sato","year":"1993","journal-title":"Biotherapy"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib82","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib83","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3476(05)81617-8","article-title":"High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates","volume":"116","author":"Laver","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib84","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nature03724","article-title":"Cellular and genetic mechanisms of self tolerance and autoimmunity","volume":"435","author":"Goodnow","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib85","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V84.12.4078.bloodjournal84124078","article-title":"Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients","volume":"84","author":"Ragnhammar","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib86","first-page":"6708","article-title":"Subcutaneous recombinant interleukin 2 in a dose escalating regimen in patients with metastatic renal cell adenocarcinoma","volume":"50","author":"Whitehead","year":"1990","journal-title":"Cancer Res"},{"issue":"Suppl. 1","key":"10.1016\/j.cytogfr.2010.03.003_bib87","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1681\/ASN.2004110959","article-title":"Epoetin-induced autoimmune pure red cell aplasia","volume":"16","author":"Casadevall","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib88","first-page":"154","article-title":"Serial immunoprecipitation assays for interferon\u2014(IFN)-beta antibodies in multiple sclerosis patients","volume":"14","author":"Lampasona","year":"2003","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib89","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.immuni.2005.07.005","article-title":"The cellular mechanism of Aire control of T cell tolerance","volume":"23","author":"Anderson","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib90","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.14.1.101","article-title":"One step ahead of the game: viral immunomodulatory molecules","volume":"14","author":"Spriggs","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib92","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1128\/IAI.67.6.3051-3054.1999","article-title":"Levels of gamma interferon and interleukin-4 are inversely related to the levels of their corresponding autoantibodies in patients with lower respiratory tract infection","volume":"67","author":"ElKarim","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/096120339400300306","article-title":"Anti-interleukin-6 and soluble interleukin-6 receptor in systemic lupus erythematosus","volume":"3","author":"Evans","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib94","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2005.12.011","article-title":"Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer","volume":"102","author":"Lokshin","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib95","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-5728(03)00136-X","article-title":"Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells","volume":"139","author":"Zhang","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib96","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-3083.1989.tb01204.x","article-title":"Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections","volume":"30","author":"Fomsgaard","year":"1989","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib97","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/HAB-1995-6206","article-title":"Comparison of anti-TNF alpha autoantibodies in plasma and from EBV transformed lymphocytes of autoimmune and normal individuals","volume":"6","author":"Tsuchiyama","year":"1995","journal-title":"Hum Antibodies Hybridomas"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib98","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","article-title":"Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan","volume":"177","author":"Inoue","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib99","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1365-2567.1999.00806.x","article-title":"Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease","volume":"97","author":"Meager","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/107999003321532475","article-title":"Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia","volume":"23","author":"Slavikova","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/HAB-1999-9106","article-title":"Induction of neutralizing autoantibodies to interferon-gamma in patients with polyneuropathy","volume":"9","author":"Elkarim","year":"1999","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.cytogfr.2010.03.003_bib102","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1005208206719","article-title":"Autoantibodies to nerve growth factor in disorders of mental development in infants","volume":"31","author":"Klyushnik","year":"2001","journal-title":"Neurosci Behav Physiol"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610110000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610110000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T22:00:09Z","timestamp":1685570409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610110000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1359610110000286"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2010.03.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}